scholarly journals 265O Anlotinib in locally advanced or metastatic radioiodine-refractory differentiated thyroid carcinoma: A randomized, double-blind, multicenter phase II trial

2020 ◽  
Vol 31 ◽  
pp. S1347
Author(s):  
Y. Chi ◽  
M. Gao ◽  
Y. Zhang ◽  
F. Shi ◽  
Y. Cheng ◽  
...  
Keyword(s):  
Thyroid Carcinoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Locally Advanced ◽  
Differentiated Thyroid Carcinoma ◽  
Double Blind ◽  
Multicenter Phase

scholarly journals A Randomized, Double Blind, Placebo-Controlled, Multicenter Phase II Trial of Allisartan Isoproxil in Essential Hypertensive Population at Low-Medium Risk

PLoS ONE ◽  
2015 ◽  
Vol 10 (2) ◽  
pp. e0117560 ◽  
Author(s):  
Ying Li ◽  
Xiao-hui Li ◽  
Zhi-jun Huang ◽  
Guo-ping Yang ◽  
Guo-gang Zhang ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Multicenter Phase ◽  
Hypertensive Population ◽  
Medium Risk

Gemcitabine and oxaliplatin combination: A multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 4544-4544 ◽  
Author(s):  
A. Font ◽  
E. Esteban ◽  
J. Carles ◽  
M. A. Climent ◽  
J. L. Gonzalez-Larriba ◽  
...  
Keyword(s):  
Phase Ii ◽  
Urothelial Cancer ◽  
Phase Ii Trial ◽  
Locally Advanced ◽  
Multicenter Phase ◽  
Metastatic Urothelial Cancer ◽  
Unfit Patients
Sign in / Sign up

Export Citation Format

Share Document